nature.com search

Loading Filters

Showing 1–18 of 18 results

Loading Filters

Research | 18 December 2020
Improvement of aesthetics in a patient with tetracycline stains using the injectable composite resin technique: case report with 24-month follow-up
British Dental Journal 229 , 774–778

Rights & permissionsfor article Improvement of aesthetics in a patient with tetracycline stains using the injectable composite resin technique: case report with 24-month follow-up . Opens in a new window.
Amendments and Corrections | 19 November 2020 | Open
Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
- Kiyomi Morita
- , Feng Wang
- , Katharina Jahn
- , Tianyuan Hu
- , Tomoyuki Tanaka
- , Yuya Sasaki
- , Jack Kuipers
- , Sanam Loghavi
- , Sa A. Wang
- , Yuanqing Yan
- , Ken Furudate
- , Jairo Matthews
- , Latasha Little
- , Curtis Gumbs
- , Jianhua Zhang
- , Xingzhi Song
- , Erika Thompson
- , Keyur P. Patel
- , Carlos E. Bueso-Ramos
- , Courtney D. DiNardo
- , Farhad Ravandi
- , Elias Jabbour
- , Michael Andreeff
- , Jorge Cortes
- , Kapil Bhalla
- , Guillermo Garcia-Manero
- , Hagop Kantarjian
- , Marina Konopleva
- , Daisuke Nakada
- , Nicholas Navin
- , Niko Beerenwinkel
- , P. Andrew Futreal
- & Koichi Takahashi
Nature Communications 11 , 1–1

Rights & permissionsfor article Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics . Opens in a new window.
Research | 21 October 2020 | Open
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
- Kiyomi Morita
- , Feng Wang
- , Katharina Jahn
- , Tianyuan Hu
- , Tomoyuki Tanaka
- , Yuya Sasaki
- , Jack Kuipers
- , Sanam Loghavi
- , Sa A. Wang
- , Yuanqing Yan
- , Ken Furudate
- , Jairo Matthews
- , Latasha Little
- , Curtis Gumbs
- , Jianhua Zhang
- , Xingzhi Song
- , Erika Thompson
- , Keyur P. Patel
- , Carlos E. Bueso-Ramos
- , Courtney D. DiNardo
- , Farhad Ravandi
- , Elias Jabbour
- , Michael Andreeff
- , Jorge Cortes
- , Kapil Bhalla
- , Guillermo Garcia-Manero
- , Hagop Kantarjian
- , Marina Konopleva
- , Daisuke Nakada
- , Nicholas Navin
- , Niko Beerenwinkel
- , P. Andrew Futreal
- & Koichi Takahashi
Nature Communications 11 , 1–17

Rights & permissionsfor article Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics . Opens in a new window.
Research | 26 May 2020 | Open
Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL
- Nicholas J. Short
- , Hagop Kantarjian
- , Rashmi Kanagal-Shamanna
- , Koji Sasaki
- , Farhad Ravandi
- , Jorge Cortes
- , Marina Konopleva
- , Ghayas C. Issa
- , Steven M. Kornblau
- , Guillermo Garcia-Manero
- , Rebecca Garris
- , Jake Higgins
- , Gabriel Pratt
- , Lindsey N. Williams
- , Charles C. Valentine III
- , Victor M. Rivera
- , Justin Pritchard
- , Jesse J. Salk
- , Jerald Radich
- & Elias Jabbour
Blood Cancer Journal 10 , 1–9

Rights & permissionsfor article Ultra-accurate Duplex Sequencing for the assessment of pretreatment <i>ABL1</i> kinase domain mutations in Ph+ ALL . Opens in a new window.
Research | 4 May 2020 | Open
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia
- Iman Abou Dalle
- , Ahmad Ghorab
- , Keyur Patel
- , Xuemei Wang
- , Hyunsoo Hwang
- , Jorge Cortes
- , Ghayas C. Issa
- , Fevzi Yalniz
- , Koji Sasaki
- , Dai Chihara
- , Allyson Price
- , Tapan Kadia
- , Naveen Pemmaraju
- , Naval Daver
- , Courtney DiNardo
- , Farhad Ravandi
- , Hagop M. Kantarjian
- & Gautam Borthakur
Blood Cancer Journal 10 , 1–10

Rights & permissionsfor article Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia . Opens in a new window.
Correspondence | 27 May 1999
Science powerhouse of Central America
- Jorge Cortés
Nature 399 , 298–298

Rights & permissionsfor article Science powerhouse of Central America . Opens in a new window.
Amendments and Corrections | 1 April 2011
Erratum: Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Nature Reviews Drug Discovery 10 , 318–318

Rights & permissionsfor article Erratum: Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond . Opens in a new window.
Research | 8 June 2018
Response kinetics and factors predicting survival in core-binding factor leukemia
- Prajwal Boddu
- , Christopher Gurguis
- , David Sanford
- , Jorge Cortes
- , Mary Akosile
- , Farhad Ravandi
- , Guillermo Garcia-Manero
- , Keyur P Patel
- , Tapan Kadia
- , Mark Brandt
- , Rita Maduike
- , Hagop Kantarjian
- & Gautam Borthakur
Leukemia 32 , 2698–2701

Rights & permissionsfor article Response kinetics and factors predicting survival in core-binding factor leukemia . Opens in a new window.
Research | 16 March 2020
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
- Pau Montesinos
- , Gail J. Roboz
- , Claude-Eric Bulabois
- , Marion Subklewe
- , Uwe Platzbecker
- , Yishai Ofran
- , Cristina Papayannidis
- , Agnieszka Wierzbowska
- , Ho Jin Shin
- , Vadim Doronin
- , Stefan Deneberg
- , Su-Peng Yeh
- , Mehmet Ali Ozcan
- , Steven Knapper
- , Jorge Cortes
- , Daniel A. Pollyea
- , Gert Ossenkoppele
- , Sergio Giralt
- , Hartmut Döhner
- , Michael Heuser
- , Liang Xiu
- , Indrajeet Singh
- , Fei Huang
- , Julie S. Larsen
- & Andrew H. Wei
Leukemia 35 , 62–74

Rights & permissionsfor article Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study . Opens in a new window.
Correspondence | 1 January 2007
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'
Nature Medicine 13 , 14–14

Rights & permissionsfor article In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' . Opens in a new window.
Reviews | 17 June 2019
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Leukemia 33 , 1835–1850

Rights & permissionsfor article Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia . Opens in a new window.
Research | 16 January 2019 | Open
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
- Haijiao Zhang
- , Samantha Savage
- , Anna Reister Schultz
- , Daniel Bottomly
- , Libbey White
- , Erik Segerdell
- , Beth Wilmot
- , Shannon K. McWeeney
- , Christopher A. Eide
- , Tamilla Nechiporuk
- , Amy Carlos
- , Rachel Henson
- , Chenwei Lin
- , Robert Searles
- , Hoang Ho
- , Yee Ling Lam
- , Richard Sweat
- , Courtney Follit
- , Vinay Jain
- , Evan Lind
- , Gautam Borthakur
- , Guillermo Garcia-Manero
- , Farhad Ravandi
- , Hagop M. Kantarjian
- , Jorge Cortes
- , Robert Collins
- , Daelynn R. Buelow
- , Sharyn D. Baker
- , Brian J. Druker
- & Jeffrey W. Tyner
Nature Communications 10 , 1–13

Rights & permissionsfor article Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms . Opens in a new window.
Research | 20 December 2018 | Open
Hundreds of genetic barcodes of the species-rich hydroid superfamily Plumularioidea (Cnidaria, Medusozoa) provide a guide toward more reliable taxonomy
Scientific Reports 8 , 1–14

Rights & permissionsfor article Hundreds of genetic barcodes of the species-rich hydroid superfamily Plumularioidea (Cnidaria, Medusozoa) provide a guide toward more reliable taxonomy . Opens in a new window.
Research | 16 May 2018 | Open
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
- Jorge Cortes
- , Kenji Tamura
- , Daniel J. DeAngelo
- , Johann de Bono
- , David Lorente
- , Mark Minden
- , Geoffrey L. Uy
- , Hagop Kantarjian
- , Lisa S. Chen
- , Varsha Gandhi
- , Robert Godin
- , Karen Keating
- , Kristen McEachern
- , Karthick Vishwanathan
- , Janet Elizabeth Pease
- & Emma Dean
British Journal of Cancer 118 , 1425–1433

Rights & permissionsfor article Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers . Opens in a new window.
Research | 12 September 2017 | Open
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
- Hui-Jen Tsai
- , Shih Sheng Jiang
- , Wen-Chun Hung
- , Gautam Borthakur
- , Sheng-Fung Lin
- , Naveen Pemmaraju
- , Elias Jabbour
- , John S. Bomalaski
- , Ya-Ping Chen
- , Hui-Hua Hsiao
- , Ming-Chung Wang
- , Ching-Yuan Kuo
- , Hung Chang
- , Su-Peng Yeh
- , Jorge Cortes
- , Li-Tzong Chen
- & Tsai-Yun Chen
Scientific Reports 7 , 1–10

Rights & permissionsfor article A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients . Opens in a new window.
Reviews | 1 October 2007
Flying under the radar: the new wave of BCR–ABL inhibitors
Nature Reviews Drug Discovery 6 , 834–848

Rights & permissionsfor article Flying under the radar: the new wave of BCR–ABL inhibitors . Opens in a new window.
Reviews | 4 August 2009
Imatinib and beyond—exploring the full potential of targeted therapy for CML
Nature Reviews Clinical Oncology 6 , 535–543

Rights & permissionsfor article Imatinib and beyond—exploring the full potential of targeted therapy for CML . Opens in a new window.
Reviews | 1 February 2011
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Nature Reviews Drug Discovery 10 , 127–140

Rights & permissionsfor article Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond . Opens in a new window.

Refine your results by…

Filters

Filter By:

Improvement of aesthetics in a patient with tetracycline stains using the injectable composite resin technique: case report with 24-month follow-up

Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia

Science powerhouse of Central America

Erratum: Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Response kinetics and factors predicting survival in core-binding factor leukemia

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Hundreds of genetic barcodes of the species-rich hydroid superfamily Plumularioidea (Cnidaria, Medusozoa) provide a guide toward more reliable taxonomy

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Flying under the radar: the new wave of BCR–ABL inhibitors

Imatinib and beyond—exploring the full potential of targeted therapy for CML

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters